Skip to content


Study links devolution in Greater Manchester to modest improvement in life expectancy

Find all our latest news, events, media and blogs.


To keep up to date follow the NIHR ARC-GM Twitter account @ARC_GM_

Study links devolution in Greater Manchester to modest improvement in life expectancy

The devolution deal which granted Greater Manchester increased control over a range of public services, including  health and social care, has been linked to a positive impact on life expectancy in a study by University of Manchester researchers.


The Health Foundation funded study also showed the benefits linked to devolution on life expectancy were felt in the most deprived local authorities where there was poorer health, suggesting a narrowing of inequality.


The study, published in The Lancet Public Health (showed that between 2014/16 and 2017/19):


  • Life expectancy was 0.2 years higher in Greater Manchester compared to a comparable control group from the rest of England. The change in Greater Manchester  was 2·2 times larger than the average change in life expectancy over the same period.


  • The change persisted throughout the period after the devolution deal  and was larger for men (0.34 years) than for women (0·06 years).


  • Statistically significant increases in life expectancy were observed in eight out of the ten local authorities in Greater Manchester, with the exceptions of Rochdale (decrease) and Oldham (no change).


  • In the short-term, life expectancy remained constant in Greater Manchester but declined in comparable areas in England. In the longer-term, life expectancy increased at a faster rate in Greater Manchester than in the rest of the country.


  • Improvements in life expectancy were larger in the local authorities with the worst levels of income deprivation and lowest life expectancy prior to devolution, when compared to areas with equally high deprivation and low life expectancy in the rest of England.


The improvements, say the researchers, may have been a result of a combination of changes in response to the devolution deals in the region, including the health and social care devolution agreement, the devolution of powers over wider determinants of health (such as housing, employment, transport, adult education, policing, and economic development), and the election of a Greater Manchester mayor.


The study, which is the first of first kind, estimated the impact of devolution on the population stratified by sex, local authority, income deprivation, and life expectancy compared to the rest of England, excluding London.


The researchers used local authority data on life expectancy at birth published by the Office for National Statistics between 2006 and 2019 to calculate the relationship.


Lead author Dr Philip Britteon Research Fellow at The University of Manchester said:


“We provide the first robust evidence on the impact of devolution in England on population health, focusing on changes occurring in Greater Manchester.


“The study shows modest improvements in life expectancy in Greater Manchester compared to comparable areas in the rest of the country from the introduction of devolution until the start of the COVID-19 pandemic in 2020, using a robust statistical method.


“This finding may have been driven by combination of changes in response to the health and social care devolution agreement, the devolution of powers over wider public services, the election of a new mayor, or earlier steps to improve population health prior to devolution.


"The findings support the suggestion that devolved systems are able to more closely identify and address the needs of local populations. However, further research is required to understand the mechanisms behind the estimated effect.”



Co-author Professor Matt Sutton from The University of Manchester and Deputy Director of the National Institute for Health and Care Research (NIHR) Applied Research Collaboration Greater Manchester (ARC-GM) said:


“In Greater Manchester many more people die younger than in most other parts of the UK; many others suffer more from serious diseases.


“However, this study has shown that devolution in Greater Manchester could improve things for the better.”



Following devolution, the Greater Manchester Health and Social Care Partnership (GMHSCP) - now part of NHS Greater Manchester Integrated Care)was established to set strategy and oversee its delivery, including the delivery of Taking Charge, the region’s five year plan.


And also part of the health and social care devolution settlement, NHS England granted the region control of its share of the national sustainability and transformation fund.


The GMHSCP policy priorities also formed components of The Greater Manchester Strategy; a plan produced by Greater Manchester Combined Authority on behalf of Greater Manchester partners, to transform and integrate public services within the conurbation.


Co-author Dr Yiu-Shing Lau from The University of Manchester said:


“These findings may provide clues to the potential success or failure of Integrated Care Systems in England.


“However, there are key differences that should be considered when drawing comparisons between the setup of the GMHSCP and the organisation of Integrated Care Systems outlined in the Health and Care Act 2022.


“Similar improvements in population health may not be replicated in Integrated Care Systems without a comprehensive representation of councils on their board.


“The success of future devolution reforms may therefore depend on other factors beyond the types and strength of powers devolved to a health system, including the extent to which health and wider public services are aligned.


“Future research will seek to further investigate the findings of the study by evaluating the impact of devolution on a range of outcome measures and investigating the activities in Greater Manchester that may have contributed to the observed change in life expectancy”



The full paper, The Impact of Devolution on Health: A Synthetic Control Analysis of Greater Manchester in England, published in The Lancet Public Health is available here.


Published 29th Sep 2022

Please complete the following form to download this item:

Once submitting your information you will be presented with a new 'Download' button to gain access to the resource.